Product Information
ARMOUR THYROID 300 MG TABLET is a brand product labeled by Allergan, Inc., priced at $2.2050 per EA under NDC 00456046401. Its NADAC has been published 444 times since Jun 18, 2014.
Strength
300 mg/1
Manufacturer
Allergan, Inc.NDC
00456046401
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SUS SCROFA THYROIDApproval Type
Unapproved
On Market Since
4/1/1996
Price Statistics
The NADAC for ARMOUR THYROID 300 MG TABLET has been published 444 times since Jun 18, 2014, and over the history we have for it it has risen 131.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2050 per EA |
|---|---|
| All-time high | $2.2162 (Aug 12, 2026) |
| All-time low | $0.9531 (Jun 18, 2014) |
| 52-week high | $2.2162 |
| 52-week low | $2.1058 |
| Median price | $1.8129 |
| Average price | $1.7374 |
| Largest weekly change | +50.0% (Jul 8, 2015) |
| Weeks tracked | 444 |
| Tracking since | Jun 18, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the THYROID, PORCINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
THYROID, PORCINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARMOUR THYROID 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARMOUR THYROID 300 MG TABLET, manufactured by Allergan, Inc., is $2.2050 per EA (NDC 00456046401), effective Sep 30, 2026.
How has the price of ARMOUR THYROID 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARMOUR THYROID 300 MG TABLET has risen 131.4%. It has been tracked across 444 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for ARMOUR THYROID 300 MG TABLET?
Since Jun 18, 2014, the NADAC for ARMOUR THYROID 300 MG TABLET has ranged from a low of $0.9531 (Jun 18, 2014) to a high of $2.2162 (Aug 12, 2026), with a median of $1.8129 per EA.
Are there cheaper alternatives to ARMOUR THYROID 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ARMOUR THYROID 300 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ARMOUR THYROID 300 MG TABLET?
ARMOUR THYROID 300 MG TABLET (NDC 00456046401) is labeled by Allergan, Inc., and CMS classifies it as a brand product.